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Cytoskeleton and Interaction with Actin Capping Protein
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CKIP-1 is a pleckstrin homology domain-containing protein that interacts with protein kinase CK2. To
elucidate the functions of CKIP-1, we generated human osteosarcoma cell lines with tetracycline-regulated
expression of Flag–CKIP-1. Flag–CKIP-1 expression resulted in distinct changes in cellular morphology.
Therefore, we examined the actin profile by immunofluorescence, quantitative measurement of phalloidin
binding, and immunoblot analysis. These studies demonstrate that Flag–CKIP-1 expression resulted in
increases in F-actin staining and protein levels of -actin. To elucidate the mechanisms behind the observed
phenotype, we utilized tandem affinity purification to isolate CKIP-1 interacting proteins. Mass spectrometry
analysis led to the identification of the actin capping protein subunits, CP and CP, as novel CKIP-1
interaction partners. Interactions were confirmed by coimmunoprecipitation and by colocalization. Further-
more, we demonstrate that Ser9 of CP is phosphorylated by protein kinase CK2 in vitro, that CP is
phosphorylated in vivo, and that treatment with a CK2-specific inhibitor results in a decrease in CP
phosphorylation. Finally, we demonstrate that CKIP-1 and CK2 inhibit the activity of actin capping protein at
the barbed ends of actin filaments. Overall, our results are consistent with CKIP-1 playing a role in the
regulation of the actin cytoskeleton through its interactions with actin capping protein.
The phosphorylation and dephosphorylation of proteins that
is mediated by a complex network of protein kinases is a key
mechanism intimately associated with the control of various
aspects of cellular regulation (reviewed in references 23 and
34). One component of these regulatory kinase networks is
protein kinase CK2. Protein kinase CK2 (formerly casein ki-
nase II) is a ubiquitous and highly conserved protein serine/
threonine kinase that is essential for viability in eukaryotic
organisms (7, 26, 52). Although its precise functions remain
poorly defined, there is mounting evidence to suggest that CK2
plays an important role in control of cell proliferation and
transformation (reviewed in references 31 and 37). A number
of studies have shown alteration in the expression of CK2 in a
variety of tumor or leukemic cells (11, 17, 53, 59). Further-
more, the targeted overexpression of CK2 in the T cells of
transgenic mice results in lymphocyte transformation. In these
mice, there is evidence for collaboration between the dysregu-
lated expression of CK2 and the c-Myc and Tal-1 oncogenes
in lymphoma development (25, 51). Taken together, these
studies demonstrate a role for CK2 as a component of the
kinase networks that regulate the growth and division of cells.
Despite the importance of CK2 in various aspects of cell reg-
ulation and its role in transformation, many questions regard-
ing its regulation in cells remain.
An emerging paradigm in signal transduction is the impor-
tance of the clustering and targeting of signaling molecules. A
notable example of this targeting is the interaction between the
pleiotropic cAMP-dependent protein kinase (PKA) and the
A-kinase anchoring proteins (AKAPs) (reviewed in references
1, 8, 14, and 44). Like PKA, protein kinase CK2 has a broad
array of potential physiological substrates and exists in numer-
ous subpopulations within a cell. Although it is evident that
CK2 has substrates in a variety of subcellular compartments, it
is unknown how distinct populations of protein kinase CK2 are
targeted to appropriate substrates. In an effort to determine
whether interacting proteins participate in the regulation of
CK2, we previously undertook a yeast two-hybrid screen to
identify novel CK2-interacting proteins. These studies led to
the identification of CKIP-1 (3).
The CKIP-1 cDNA encodes a 409-amino-acid protein with
an amino-terminal pleckstrin homology (PH) domain and a
leucine-rich region within its carboxy terminus. Contained
within CKIP-1 are five PXXP motifs, two of which match the
consensus for cyclin-dependent kinases and mitogen-activated
kinases. We have previously shown that CKIP-1 localizes to the
plasma membrane and that the PH domain is required for
binding to phospholipids in cells and in vitro (3, 40). Moreover,
we have demonstrated that the pleckstrin homology domain of
CKIP-1 is required for interactions with CK2 and for the re-
cruitment of CK2 to the plasma membrane (40). It was also
recently reported that CKIP-1 is induced during muscle differ-
entiation and that it plays a role in phosphatidylinositol 3-ki-
nase-regulated differentiation in C2C12 cells (46). On the basis
of these observations, we hypothesized that CKIP-1 functions
to target CK2 to specific cellular compartments thereby facil-
itating phosphorylation of particular substrates and perhaps at
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the same time limiting access to nonappropriate targets in an
analogous way to the regulation of cAMP-dependent protein
kinase by the AKAPs.
To understand the functions of CKIP-1 and its potential role
in regulating protein kinase CK2, we generated cell lines with
tetracycline-regulated expression of Flag–CKIP-1. Our objec-
tives were to examine the phenotype associated with CKIP-1
expression and to elucidate the role, if any, that protein kinase
CK2 plays in this phenotype. Here we report that CKIP-1
functions in the regulation of the actin cytoskeleton and cell
morphology and forms stable interactions with the het-
erodimeric actin-capping protein. Furthermore, we show that
the -subunit of the actin capping protein (CP) is phosphor-
ylated by protein kinase CK2 on Ser9 in vitro, that CP is
phosphorylated in osteosarcoma cells, and that treatment with
a CK2-specific inhibitor results in a decrease in CP phosphate
incorporation. Finally, we show that CKIP-1 and protein ki-
nase CK2 inhibit the activity of CP at the barbed ends of actin
filaments.
MATERIALS AND METHODS
Antibodies. Monoclonal antibodies against the Flag epitope and polyclonal
antibodies directed against -actin were purchased from Sigma-Aldrich (St.
Louis, Mo.). Monoclonal antibodies directed at the HA epitope (clone 12CA5)
and anti-HA-biotin antibodies were purchased from Roche Applied Science
(Indianapolis, Ind.). Polyclonal antibodies directed against green fluorescent
protein (GFP) were purchased from Clontech (Palo Alto, Calif.). Antibodies
against the CP (MAb 5B12.3) and CP (MAb 3F2.3) subunits of the actin
capping protein (49) were obtained from the Iowa Hybridoma Bank developed
under the auspices of the National Institute of Child Health and Human Devel-
opment and maintained by the Department of Biological Sciences, University of
Iowa (Iowa City, Iowa). Monoclonal antibodies against -tubulin were a gener-
ous gift from Lina Dagnino (Department of Pharmacology, University of West-
ern Ontario). Antibodies directed against CKIP-1 were raised in rabbits against
glutathione S-transferase (GST)-CKIP (positions 308 to 409) (3).
Plasmid constructs. Flag-CKIP was generated by PCR amplification using the
forward primer 5 GAT AAG CTT GCC ACC ATG GAC TAC AAA GAC
GAT GAC GAC AAG GAA TTC ATG ATG AAG AAG AAC 3 and the
reverse primer 5 GCC CGG AAT TAG CTT GGC TGC AGG TGC GGC
CGC CGC TGC CCTCAC ATC 3. The resulting 1,300-bp fragment was sub-
cloned into the pRc/CMV vector using the HindIII and NotI sites. For genera-
tion of a cell line with tetracycline-regulated expression, Flag–CKIP-1 was cut
out of pRc/CMV with HindIII and NotI, extended with Klenow, and ligated into
the BamHI sites of the vector pTRE. Deletion constructs Flag–CKIP-1(133–
346), Flag–CKIP-1(133–308), and Flag–CKIP-1(133–250) were generated by
PCR amplification using the forward primer 5 GCC GAA TTC CGA GCC
AAG AAC CGT ATC TTG GAT GAG GTC 3 and the reverse primers 5AGC
AGG CGG CCG CCG TTA AGA ATC CGG CGG AGA CCG AGG GGG
GTC 3, 5 CTT GTG CGG CCG CCG TTA GAT CCG GGA CAG CTG CCC
CGG GTT GGG 3, and 5 CTG GGG CGG CCG CCG TTA CCC TTT GTC
TGT TTT TTC CCA AGG TCG 3, respectively. Similarly, deletion constructs
Flag–CKIP-1(193–346) and Flag–CKIP-1(235–346) were generated using the
forward primers 5 ATC GAA TTC GAA GAC CCT TCC CCT GAG GAA
CCA ACC TCT 3 and 5 CAG GAA TTC GCA GAC CGG GCA AGC AGT
CTC TTC CGA CCT 3, respectively, and the reverse primer 5 AGC AGG
CGG CCG CCG TTA AGA ATC CGG CGG AGA CCG AGG GGG GTC 3.
The resulting fragments were subcloned into pRc/CMV vector by using the
HindIII and NotI sites. TAP-CKIP was generated by PCR amplification using
the forward primer 5 G AGA TCT GAA TTC ATG ATG AAG AAG AAC
AAT 3 and the reverse primer 5 CAG GTC GAC CCC AGC GGC CGC TCA
CAT CAG 3. Vectors expressing the TAP tag were a generous gift from Kath-
leen L. Gould, Vanderbilt University School of Medicine, Nashville, Tenn. (60).
The TAP tag was amplified out of pFA6 using the forward primer 5 GGG GCC
ACC AAG CTT ATG AAA GCT GAT GCG CAA CAA AAT AAC TTC 3 and
the reverse primer 5 TTC AGA TCT CCC ATA ATC AAG TGC CCC GGA
GGA 3. TAP-CKIP was assembled by a second round of PCR using the forward
primer 5 GGG GCC ACC AAG CTT ATG AAA GCT GAT GCG CAA CAA
AAT AAC TTC 3 and the reverse primer 5 CAG GTC GAC CCC AGC GGC
CGC TCA CAT CAG 3. The resulting 1,800-bp fragment was subcloned into
pRc/CMV using the HindIII and NotI sites. CP constructs for expression of
HA-tagged CP and HA-tagged CPS9A were generated by PCR amplification
using the forward primers 5 AAA AGC GGC CGC ATG GCC GAC TTC GAT
GAT CGT GTG TCG GAT GAG 3 and 5 AAA AGC GGC CGC ATG GCC
GAC TTC GAT GAT CGT GTG GCG GAT GAG GAG AAG GTA CGC 3,
respectively, and the reverse primer 5 AAA AGC GGC CGC TTA AGC ATT
CTG CAT TTC TTT GCC AAT CTT 3. The resulting 875-bp fragment was
subcloned into the NotI sites of pRc/CMV immediately downstream of the
HA-tag. Similarly, Myc-tagged CP was generated using the forward primer 5
AAA AGC GGC CGC ATG AGC GAT CAG CAG CTG GAC TGC GCC
TTG GAC 3 and the reverse primer 5 AAA AGC GGC CGC TCA ACA CTG
CTG CTT TCT CTT CAA GGC CTC 3. The resulting 800-bp fragment was
subcloned into the NotI sites of pRc/CMV immediately downstream of the Myc
tag. All constructs were verified by sequencing.
shRNA generation and transfection. Two small interfering RNA sequences
were selected from the open reading frame of CKIP-1: TTTGACCTGAGTGA
CTATG (nucleotides 208 to 226) and AAATTCTGCGGGAAAGGGATTTT
(nucleotides 85 to 107) (46). Sequences were verified to target only CKIP-1 by
BLAST analysis. As a control, a scrambled sequence (ACTGTACATCGCACT
TCTG) with similar GC content that generated no significant BLAST results
was constructed. Sense and antisense primers were obtained, annealed, and
subcloned into pSuper vector (a generous gift of Reuven Agami) using the BglII
and HindIII sites (4). Constructed shRNAs were verified by sequencing. For
mammalian cell expression, pSuper alone, scrambled sequence, or a combination
of CKIP-1 shRNA were transfected using Fugene 6 (Roche) as described by the
manufacturer. The vector pEGFP-C3 was included as a transfection marker,
using a ratio of small hairpin RNA (shRNA) to pEGFP-C3 of 9:1.
Generation of cell lines. UTA6 cells were derived from the human osteosar-
coma cell line U2-OS and express the tetracycline-regulated transcriptional ac-
tivator protein (a generous gift from Christoph Englert, Forschungszentrum,
Germany [15]). Cell lines with tetracycline-regulated expression of Flag–CKIP-1
were generated by transiently transfecting UTA6 cells with Flag–CKIP-1/pTRE
and pTK-Hyg in the presence of tetracycline (1.5 g/ml). Drug selection with
hygromycin (500 g/ml) and G418 (460 g/ml) began 4 days after transfection.
Once stably transfected colonies were formed, they were picked and transferred
to 96-well plates. Individual colonies of Flag–CKIP-1-expressing cells were
grown up and screened for tight inducible expression by Western blot analysis.
Cell labeling and TBB treatment. DC1.4 cells induced for expression of Flag–
CKIP-1 were labeled with carrier-free [-32P]orthophosphate (ICN) by washing
cells three times with phosphate-free Dulbecco’s modified Eagle’s medium and
then culturing cells in the phosphate-free medium supplemented with 0.33mCi
[-32P]orthophosphate for 6 hours. TBB (4,5,6,7-tetrabromo-2-azabenzimida-
zole) treatment (28, 45, 47, 50, 54) was performed by incubating cells with 75 M
TBB or dimethyl sulfoxide (DMSO) carrier for 18 h prior to cell labeling.
Subsequently, cells were labeled for 6 hs as described above in the presence of 75
M TBB or carrier alone.
Immunofluorescence. Cells (150,000) grown on sterile coverslips were main-
tained in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal
bovine serum (Gibco/BRL) at 37°C in an atmosphere of 5% CO2. The coverslips
were washed three times with phosphate-buffered saline (PBS) and fixed for 30
min in 3.7% paraformaldehyde at 37°C. The cells were permeabilized for 5 min
with 0.1% Triton X-100 in PBS and then treated with for 5 min with 0.1 M glycine
in PBS. The coverslips were washed with PBS and then incubated with primary
antibody (anti-FLAG at 1:250 or anti-CP at 1:100) for 1 h at 37°C. Following
washing with PBS, secondary antibodies conjugated to tetramethylrhodamine-5-
isothiocyanate (TRITC) or fluorescein isothiocyanate (FITC) (both at 1:1,000)
were added for 1 h in the dark. The coverslips were washed, mounted with
AirVol (Air Products and Chemicals Inc., Allentown, Pa.), and visualized using
a Zeiss LSM 410 confocal microscope. Where noted, cells were prepermeabilized
for 30 s with buffer containing 0.5% Triton X-100, 50 mM NaCl, 3 mM MgCl2,
0.3 M sucrose, and 10 mM HEPES (pH 6.9) prior to paraformaldehyde fixation.
Phalloidin staining, extraction, and quantitation. For TRITC-phalloidin
staining of cells, coverslips were washed three times with PBS and fixed for 30
min in 3.7% paraformaldehyde at 37°C. The coverslips were stained with
TRITC-phalloidin (1 g/ml) for 40 min in the dark, washed with PBS, and
mounted with Airvol. Slides were visualized using a Zeiss LSM 410 confocal
microscope. Actin quantitation experiments were performed by the method of
Machesky et al. (33). Briefly, triplicate plates of cells were washed twice with PBS
and scraped into 400 l of extraction buffer (10 mM PIPES, 190 mM K2PO4 plus
10 mM KH2PO4, 5 mM EGTA, 2 mM MgCl2, 0.1% Triton X-100) with 3.7%
paraformaldehyde and 2 M TRITC-phalloidin and rocked for 1 h at room
temperature. The cells were pelleted by brief centrifigation and washed twice
3520 CANTON ET AL. MOL. CELL. BIOL.
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with 200 l of 0.1% saponin–20 mM KPO4–10mM PIPES–5 mM EGTA–2 mM
MgCl2. The bound phalloidin was extracted in 1 ml of methanol by rocking for
1 h at room temperature, and TRITC levels were determined by reading the
emission at 563 nm following excitation at 542 nm. Values were normalized to
the overall protein concentration and represent the average for three 10-cm
plates and the standard deviation from two independent experiments.
Immunoprecipitations. For immunoprecipitations, 10-cm plates of U2-OS
cells were lysed on ice in 0.5 ml of NP-40 lysis buffer (50 mM Tris [pH 7.5], 150
mM NaCl, 1% NP-40, 1% aprotinin, 0.1 mM phenylmethylsulfonyl fluoride
[PMSF]). The lysates were sonicated on ice with three 10-s bursts and then
centrifuged at 55,000 rpm in a Beckman TL100.2 rotor for 15 min at 4°C. The
cleared lysates were subjected to immunoprecipitation using anti-Flag M2 anti-
bodies bound to protein G-Sepharose or anti-GFP or anti-HA antibodies bound
to protein A-Sepharose. Following incubation for 1 h at 4°C, the lysates were
centrifuged briefly and the protein A/G-Sepharose beads were washed four times
with lysis buffer. Following the last wash, bound proteins were eluted from the
beads by the addition of sample buffer. For large-scale Flag immunoprecipita-
tions, four 15-cm plates were used. For immunokinase experiments, the protein
A/G-Sepharose beads were washed three times with 50 mM Tris (pH 7.5)–120
mM NaCl–10 mM MgCl2 and phosphorylated with recombinant GST-CK2 for
30 min at 30°C in the presence of [-32P]ATP. Subsequently, the beads were
washed four times with lysis buffer and bound proteins were eluted from the
beads by the addition of sample buffer.
Immunoblot analysis. Samples were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) (12% polyacrylamide) using
the method of Laemmli (29). Proteins were transferred to polyvinylidene diflu-
oride (PVDF) membranes for 1 h at 15 V and 0.3 A using semidry transfer
apparatus (Bio-Rad, Hercules, Calif.). Anti-Flag blotting was performed as spec-
ified by the manufacturer, using anti-Flag M2 at 1:2,500 and goat anti-mouse
secondary antibody (1:20,000) conjugated to horseradish peroxidase. Anti--
actin blots were performed as specified by the manufacturer, using anti--actin at
1:2,000 and goat anti-rabbit secondary antibody (1:25,000) conjugated to horse-
radish peroxidase. Immunoblotting with anti--tubulin antibodies was performed
by blocking for 1 h in 5% skim milk powder followed by incubation with primary
antibody (1:100). Immune complexes were detected using goat anti-mouse sec-
ondary antibodies (1:5,000) conjugated to horseradish peroxidase. Anti-CP and
anti-CP blotting was performed by blocking membranes for 1 h in 3% bovine
serum albumin followed by incubation with primary antibodies at dilutions of
1:200 and 1:600, respectively. In both cases, secondary antibody was used at a
dilution of 1:5,000. Anti-HA-biotin blotting was performed by blocking for 1 h in
3% bovine serum albumin followed by incubation with primary antibody (1:500).
Immune complexes were detected using peroxidase-conjugated anti-biotin (1:
10,000). Where indicated, membranes were stripped with 0.1 M NaOH for 30
min.
Tandem affinity purification. U2-OS cells (108 cells) were either nontrans-
fected or transiently transfected with tandem affinity purification (TAP)-tagged
(42) CKIP-1 using the calcium phosphate method. Cells were scraped off plates,
and the resulting cell pellet was lysed in NP-40 lysis buffer (50 mM Tris [pH 7.5],
150 mM NaCl, 1% NP-40, 1% aprotinin, 0.1 mM PMSF) for 30 min on ice. The
lysates were sonicated on ice with five 10-s bursts and then centrifuged at 55,000
rpm in a Beckman TL100.2 rotor for 25 min at 4°C. The cleared lysate was
adjusted to 10 mM Tris (pH 7.5)–150 mM NaCl–0.2% NP-40–0.5 mM dithio-
threitol DTT and bound to 200 l of immunoglobulin G IgG-Sepharose beads
(Amersham Biosciences, Piscataway, N.J.) overnight at 4°C. Following extensive
washing in the above buffer plus 0.5 mM EDTA, CKIP-1 and associated proteins
were cleaved from the beads by treatment with tobacco etch virus (Tev) protease
for 2 h. Eluate (1 ml) was collected, adjusted to 2 mM CaCl2, and incubated with
200 l of calmodulin beads (Stratagene, La Jolla, Calif.) in the presence of Ca2
for 2 h. The calmodulin beads were washed extensively in the presence of Ca2
and eluted with boiling sample buffer. CKIP-1 and associated proteins were
separated by SDS-PAGE and visualized using the colloidal Coomassie blue stain
GelCode Blue (Pierce, Rockford, Ill.).
Phosphorylation of CP by protein kinase CK2. TAP purification was per-
formed as described above with the following additions: CKIP-1 and associated
proteins were bound to calmodulin beads (100 l) in the presence of Ca2 for
2 h. Following extensive washing with buffer containing Ca2, beads were resus-
pended in 50 mM KCl–20 mM Tris-HCl (pH 7.5)–10 mM MgCl2–2 mM CaCl2
with 20 M [-32P]ATP and phosphorylated with 250 U of protein kinase CK2
(Calbiochem, San Diego, Calif.) for 30 min at 30°C. The beads were washed
extensively in buffer containing Ca2 and eluted with boiling sample buffer.
Following separation by SDS-PAGE, the gel was dried and radiolabeled proteins
were visualized using a PhosphorImager (Molecular Dynamics).
In-gel tryptic digests, mass spectrometry, and analysis. Bands were excised
from gels, cut into 1-mm cubes, and washed in 100 l of double-distilled ddH2O
for 15 mins. The stain was removed by repeatedly washing the gel pieces with 200
l of 50:50 acetonitrile:ddH2O for 15 min with shaking. The gel pieces were
dehydrated and rehydrated with 40 l of acetonitrile and 40 l of 100 mM
ammonium bicarbonate, respectively, and evaporated to dryness with a Speed-
vac. Digests were performed overnight at 37°C using 1 g of non-self-cleaving
trypsin (Promega, Madison, Wis.) in 30 l of 25 mM ammonium bicarbonate–2.5
mM CaCl2. Peptides were extracted five times with 30 l of acetonitrile and 30
l of 5% formic acid by vortexing and sonication. Samples were evaporated to
dryness with a Speedvac and resuspended in 5l of 0.1% trifluoroacetic acid
prior to mass spectrometry analysis. Matrix-assisted laser desorption ionization
(MALDI) analyses were performed on a Micromass (Manchester, United King-
dom) Reflectron MALDI-time-of-flight (TOF) instrument. Tandem mass spec-
trometry-mass spectrometry (MS/MS) analyses were performed on a quadru-
pole-time-of-flight mass spectrometer (Q-TOF 2; Micromass). Peptide mapping
and database analyses were performed online using the search engine Mascot
(www.matrixscience.com). All peptide sequences were manually verified.
Actin depolymerization assay. F-actin at 5 M (20% pyrene-labeled) was
mixed with CP (1 nM), incubated for 5 min at room temperature, and diluted
50-fold into G buffer (2 mM Tris-HCl [pH 8.0], 0.2 mM ATP, 0.1 mM DTT, 0.2
mM CaCl2) at 25°C in a fluorometer cuvette with a stirring bar (57). The
decrease in pyrene fluorescence intensity accompanying actin depolymerization
was monitored for 400 s after dilution. To test the effect of CKIP-1 and protein
kinase CK2, 1 nM CP was incubated for 5 min with different concentrations of
proteins before addition to F-actin.
Spectrin–F-actin seeded actin polymerization assay. Actin polymerization as-
says were performed essentially as described previously (57). Briefly, actin poly-
merization from spectrin F–actin seeds (SAS) was assayed using 1 M actin (5%
pyrene labeled), 4 nM CP, 0.4 to 0.5 nM SAS, and different concentrations of
CKIP-1 and protein kinase CK2 in ATP–G-buffer (10 mM imidazole [pH 7.0],
0.2 mM ATP, 0.5 mM DTT, 0.2 mM CaCl2). The pyrene fluorescence (excitation,
368 nm; emission, 386 nm) was monitored for 500 s at 25°C.
Actin uncapping assays. Actin uncapping assays were performed as described
previously (49). Briefly, actin polymerization was initiated by addition of SAS
and CP to monomeric actin (1.5 M, 5% pyrene labeled). CKIP-1 (80 nM),
protein kinase CK2 (250 nM), and phosphatidylinositol-4,5-bisphosphate PIP2
(40 M) were added to the polymerization reaction mixture at 250 s, and the
fluorescence was monitored for a total of 500 s.
RESULTS
Inducible expression of Flag–CKIP-1. As a first step toward
elucidation of the cellular functions of CKIP-1, we generated
human osteosarcoma (U2-OS) cell lines, previously shown to
express endogenous CKIP-1 (3), with tetracycline-regulated
expression of Flag-tagged CKIP-1. For these experiments,
Flag–CKIP-1 was ligated into the pTRE vector immediately
downstream of the tetracycline-responsive promoter. Follow-
ing transfection and drug-selection, stably transfected colonies
were picked and screened for highly regulated inducible ex-
pression of Flag–CKIP-1 in the absence of tetracycline. Cells
grown in the presence of tetracycline or induced for 24 h were
harvested, and the lysates derived from these cells were sub-
jected to immunoblotting with anti-Flag M2 antibody. As
shown, the cell line DC1.4 exhibits strong induction and tight
regulation (Fig. 1A). As a complementary approach, DC1.4
cells grown in the presence or absence of tetracycline were
fixed, labeled with anti-Flag M2 antibodies, and visualized by
confocal microscopy (Fig. 1B). Again, induction of Flag–
CKIP-1 is tightly regulated. Furthermore, this analysis demon-
strates that all cells express Flag–CKIP-1 and that it is localized
predominantly at the plasma membrane in accordance with
our previous results (40). Although the precise level of induc-
tion of CKIP-1 that occurs during muscle differentiation was
not reported, the level of CKIP-1 induction achieved following
tetracycline removal (10-fold by immunoblot analysis) ap-
VOL. 25, 2005 CKIP-1 REGULATES THE ACTIN CYTOSKELETON 3521
 o
n
 January 6, 2014 by W








pears to be within the range of induction of CKIP-1 that was
previously observed (46).
Expression of Flag–CKIP-1 induces changes in cell mor-
phology. To characterize the effects of Flag–CKIP-1 expression
in U2-OS cells, we examined microscopic images of DC1.4
cells grown in the presence or absence of tetracycline for 24 h
(Fig. 2A). As shown, DC1.4 cells grown in the presence of
tetracycline exhibit a consistent cellular morphology identical
to that observed with the parent U2-OS cell line. However,
after induction of Flag–CKIP-1 expression by the removal of
tetracycline from the growth medium for 24 h, DC1.4 cells
were consistently more elongated and exhibited morphology
consistent with fibroblastic cells. To quantify this observation,
we performed morphometric analysis of cells grown in the
presence or absence of tetracycline by measuring the perimeter
of 100 cells from numerous fields of view (Fig. 2B). The
results of this experiment clearly show that cells expressing
Flag–CKIP-1 have a significantly larger perimeter than do cells
grown in the presence of tetracycline.
To extend these studies, we tested whether targeting Flag-
tagged and endogenous CKIP-1 with shRNA could block the
change in cell morphology. DC1.4 cells grown in the presence
of tetracycline were transfected with empty vector or vector
containing a scrambled shRNA or a combination of shRNA
sequences directed against CKIP-1 (Fig. 2C, left panel). Flag–
CKIP-1 expression was induced 18 h later by the removal of
tetracycline from the growth medium, and lysates derived from
these cells were subjected to immunoblotting with anti-Flag
M2 antibodies. To ensure equal loading, the membrane was
stripped and reprobed with antibodies against -tubulin. Sim-
ilarly, parental U2-OS cells were transfected with empty vec-
tor, scrambled shRNA, or a combination of shRNA directed
against CKIP-1 (Fig. 2C, right panel), and lysates derived from
these cells were analyzed by immunoblotting with anti-CKIP-1
and anti--tubulin antibodies. These data demonstrate that
treatment with shRNA results in a partial knockdown of Flag–
CKIP-1 and endogenous CKIP-1 compared to vector alone or
a scrambled sequence.
To test the ability of shRNA to block the morphology
change associated with Flag–CKIP-1 expression, DC1.4 cells
grown in the presence of tetracycline were transfected with
empty vector, scrambled shRNA, or a combination of CKIP-1
shRNA along with pEGFP-C3 as a transfection marker. Flag–
CKIP-1 expression was induced 18 h later by the removal of
tetracycline from the growth medium, and morphometric anal-
ysis of GFP-positive cells was performed. Treatment with
CKIP-1 shRNA, but not empty vector or a scrambled se-
quence, was able to partially block the morphology change
associated with Flag–CKIP-1 expression. These results are
consistent with the partial knockdown of Flag–CKIP-1 that is
FIG. 1. Tetracycline-regulated expression of Flag-tagged CKIP-1. Flag-tagged CKIP-1 is expressed in the cell line DC1.4 under the tight control
of tetracycline (tet) as shown by immunoblotting (A) and immunofluorescence (B). (A) DC1.4 cells were grown in the presence or absence of
tetracycline for 24 h to induce the expression of Flag–CKIP-1. Extracts were prepared, and 35 g of total-cell lysate was separated by SDS-PAGE,
transferred to a polyvinylidene difluoride membrane, and immunoblotted with anti-Flag M2 antibodies. (B) DC1.4 cells grown in the presence or
absence of tetracycline were fixed, permeabilized, and stained with anti-Flag M2 antibody and TRITC–goat anti-rabbit antibody.
3522 CANTON ET AL. MOL. CELL. BIOL.
 o
n
 January 6, 2014 by W








FIG. 2. Expression of Flag–CKIP-1 induces changes in cell morphology that are partially blocked by treatment with shRNA. (A and B)
Expression of Flag–CKIP-1 induced changes in cell morphology as shown by light microscopy (A) and Morphometric analysis (B). (A) DC1.4 cells
were grown in the presence or absence of tetracycline (tet), and microscopic images were captured at 0 and 24 h. (B) The perimeter of these cells
were measured and quantitated using Northern Elite software. Results shown represent the average of 100 cells in six fields; error bars indicate
standard deviation. (C and D) Treatment of DC1.4 and parental U2-OS cells with CKIP-1 shRNA reduced the levels of Flag–CKIP-1 and
endogenous CKIP-1, respectively, and partially blocked morphology changes in DC1.4 cells. (C) Transfection of DC1.4 (left panels) and U2-OS
(right panels) cells with CKIP-1-targeting shRNA reduced the expression of Flag–CKIP-1 and endogenous CKIP-1, respectively, compared to that
of empty vector or a scrambled sequence. To ensure equal loading, the membrane was stripped and reprobed with anti--tubulin. (D) DC1.4 cells
cotransfected with pEGFP-C3 along with empty vector, scrambled shRNA, or CKIP-1 shRNA were induced for expression of Flag–CKIP-1. Cell
perimeter measurements of GFP-positive cells were obtained 24 hs later, as described for panel B.
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observed and suggest that the change of morphology in DC1.4
cells is a direct result of Flag–CKIP-1 expression. At the level
of resolution of the morphometric analyses that were per-
formed, the partial knockdown of endogenous CKIP-1 in
U2-OS cells did not elicit a significant quantifiable alteration in
cell morphology (data not shown). However, more detailed
investigation beyond the scope of the present investigation is
required to rigorously examine subtle changes in morphology
and/or the actin cytoskeleton that may result from a partial
knockdown of endogenous CKIP-1.
Flag–CKIP-1 expression increases phalloidin binding and
cellular -actin levels. Based on microscopic examination, it is
evident that expression of Flag-CKIP-1 leads to changes in
overall cell morphology. In order to further characterize this
phenotype, we examined the F-actin profile of these cells using
fluorescently-labeled phalloidin. DC1.4 cells grown in the pres-
ence () or absence (	) of tetracycline for 24 hours were
fixed, stained with TRITC-phalloidin and visualized by confo-
cal microscopy (Fig. 3A). When grown in the presence of
tetracycline, DC1.4 cells exhibit predominantly peripheral ac-
tin stress fibers. However, DC1.4 cells expressing Flag–CKIP-1
exhibit stronger overall staining and show an increase in the
number of transverse actin stress fibers. To confirm that cells
expressing Flag–CKIP-1 have increased overall phalloidin
binding, we performed quantitative measurements of TRITC-
phalloidin binding (Fig. 3B). The data, normalized to extract
protein, clearly show that DC1.4 cells exhibit increased phal-
loidin binding by 1.5-fold. Taken together, these data demon-
strate that expression of Flag–CKIP-1 results in an increase in
the overall amount of cellular F-actin.
Increased phalloidin binding in DC1.4 cells could result
from either increased polymerization or increased amounts of
actin. To determine if the overall cellular levels of actin are
affected by Flag–CKIP-1, DC1.4 cells grown in the presence or
absence of tetracycline were harvested with boiling sample
buffer after a 24-h induction. As shown in Fig. 3C, expression
of Flag–CKIP-1 clearly results in an increase in the cellular
levels of -actin. To ensure equal protein loading on the gel,
the membrane was stripped and reprobed with anti--tubulin
antibodies (Fig. 3C). Quantification of -actin levels by densi-
tometry and normalization to -tubulin levels illustrated that
-actin levels are increased by approximately 60% in cells
expressing Flag–CKIP-1, an increase that corresponds well to
the increase in the level of F-actin. To extend these studies, we
were interested in examining if CKIP-1 colocalizes with the
actin cytoskeleton in mammalian cells (Fig. 3D). For these
experiments, a construct expressing GFP-actin was transiently
transfected into DC1.4 cells grown in the absence of tetracy-
cline. Prior to fixing and immunofluorescence, these cells were
pre-permeabilized with buffer containing Triton X-100 to re-
move all noncytoskeletal proteins. Immunofluorescence with
anti-Flag M2 antibodies was performed, and the coverslips
were mounted and visualized by fluorescence microscopy.
With pre-permeabilization of the cells, Flag-CKIP-1 colocal-
izes with transverse actin stress fibers, as shown in the image
overlaying Flag-CKIP with GFP-actin. This colocalization was
not apparent when the cells were not pre-permeabilized, indi-
cating that the majority of CKIP-1 localizes to the plasma
membrane. Taken together with the results from the previous
figure, these data suggest direct association of Flag–CKIP-1
with microfilaments in mammalian cells.
Identification of CKIP-1-associated proteins by tandem af-
finity purification of CKIP-1 and large-scale immunoprecipi-
tations. To understand the mechanistic basis for the phenotype
associated with Flag–CKIP-1 expression, we utilized TAP (42)
and large-scale immunoprecipitations to identify CKIP-1 inter-
action partners. A schematic illustration of CKIP with an ami-
no-terminal TAP tag composed of protein A domains and a
calmodulin-binding peptide is shown in Fig. 4A. Briefly,
U2-OS cells (108) were either nontransfected or transiently
transfected with TAP-CKIP by using the calcium phosphate
method. The cells were harvested, and the lysates derived from
them were purified on IgG-Sepharose beads, cleaved with Tev
protease, and then bound to calmodulin beads in the presence
of Ca2. Following extensive washing, proteins were eluted
from the calmodulin beads with boiling sample buffer. For
large-scale immunoprecipitations, DC1.4 cells grown in the
presence or absence of tetracycline for 24 h were harvested and
the lysates were subjected to immunoprecipitation with anti-
Flag M2 antibody. For both experiments, CKIP-1 and associ-
ated proteins were eluted, separated by SDS-PAGE, and
stained with Gel Code Blue. Representative examples of TAP
and large-scale immunoprecipitations are shown (Fig. 4B and
C, respectively). Bands corresponding to CP and CP were
excised and subjected to in-gel trypic digestion in preparation
for MS. Importantly, none of these bands were isolated when
cells were transfected with TAP constructs lacking the CKIP-1
fusion (data not shown) or in the absence of Flag–CKIP-1,
indicating that the presence of these bands is dependent on
CKIP-1. The band labeled TAP-CKIP was positively identified
using MALDI MS (data not shown). The two remaining bands
of approximately 35 and 30 kDa were identified by tandem
MS/MS as the heterodimeric actin capping protein subunits
CP and CP, respectively (Fig. 4D and E). For each protein,
sequence data for one peptide and a peptide match summary
highlighting three peptides that were sequenced for each pro-
tein are shown. Our results demonstrate that the het-
erodimeric actin capping protein is a novel CKIP-1-interacting
protein. In a similar respect, it is noteworthy that yeast two-
hybrid studies to identify CK2-interacting proteins previously
led to the identification of CP as a potential interacting partner
of protein kinase CK2 (19).
Coimmunoprecipitation and colocalization of CKIP-1 and
actin capping protein. To further confirm interactions between
CKIP-1 and actin capping protein, we performed coimmuno-
precipitation and colocalization studies. DC1.4 cells grown in
the presence or absence of tetracycline for 24 h were har-
vested, and the resulting lysates were subjected to immunopre-
cipitation with anti-Flag M2 antibodies. Proteins were sepa-
rated by SDS-PAGE and immunoblotted with antibodies
against CP and CP (Fig. 5A). As expected on the basis of
results illustrated in Fig. 4, both CP and CP are found in
complexes with Flag–CKIP-1 in the absence of tetracycline.
Likewise, GFP-CKIP interacts with capping protein (Fig. 5B).
U2-OS cells transiently transfected with GFP or GFP–CKIP-1
were harvested, and the derived lysates were immunoprecipi-
tated with anti-GFP antibodies. Following separation by SDS-
PAGE, immunoblotting was performed with antibodies against
CP and CP. In agreement with the anti-Flag immunopre-
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FIG. 3. Flag–CKIP-1 expression increases phalloidin binding and cellular -actin levels. Cells expressing Flag–CKIP-1 have increased F-actin
levels as shown by immunofluorescence (A) and quantitation of extracted TRITC-phalloidin (B). (A) DC1.4 cells grown in the presence of
tetracycline (tet) or induced for Flag–CKIP-1 expression were fixed and stained with TRITC-phalloidin. (B) DC1.4 cells grown in the presence or
absence of tetracycline for 48 h were scraped off plates, permeabilized, and labeled with TRITC-phalloidin as described in Materials and Methods.
Bound phalloidin was extracted with methanol and quantitated by fluorescence emission of TRITC at 563 nm following excitation at 542 nm. Data
represent the average of two independent experiments, each using three 100-mm plates of DC1.4 cells normalized for protein concentration (error
bars indicate standard deviation). (C) Flag–CKIP-1 expression causes an increase in -actin levels. DC1.4 cells were grown in the presence or
absence of tetracycline for 24 h. Lysates were prepared by extraction with boiling sample buffer, and proteins were separated by SDS-PAGE,
transferred to a PVFD membrane, and immunoblotted with anti--actin antibodies. To ensure equal loading, the membrane was stripped and
reprobed with anti--tubulin. (D) CKIP-1 colocalizes with F-actin in DC1.4 cells. GFP-actin was transfected into DC1.4 cells expressing
Flag–CKIP-1. Cells were pre-permeabilized with Triton X-100-containing buffer, fixed, and stained with anti-Flag M2 antibody as described in
Materials and Methods.
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FIG. 4. Identification of CKIP-1-associated proteins by TAP and large-scale immunoprecipitations. Identification of the heterodimeric actin-
capping proteins, CP and CP, by tandem mass spectrometry is shown. (A) Schematic representation of CKIP-1 with an amino-terminal TAP
tag that is composed of protein A and a calmodulin binding peptide separated by a TEV cleavage site. (B) U2-OS cells (108 cells) were untreated
(Non-trans) or transfected with TAP–CKIP-1. The cells were harvested and subjected to tandem affinity purification as described in Materials and
Methods. (C) For large-scale immunoprecipitations (IP), DC1.4 cells grown in the presence or absence of tetracycline (tet) for 24 h were harvested,
and the lysates were subjected to immunoprecipitation with anti-Flag M2 antibody. For both experiments, CKIP-1 and associated proteins were
eluted, separated by SDS-PAGE, and stained with Gel Code Blue. Bands corresponding to CP and CP, marked with * and #, respectively, were
excised, processed, and analyzed by tandem MS/MS and MALDI MS (data not shown). (D) Sequence data of one representative peptide and
peptide match summary for CP. (E) Sequence data of one representative peptide and peptide match summary for CP. Matched peptides and
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cipitations, both CP and CP interact specifically with GFP-
CKIP but fail to interact with GFP alone.
To extend these results, we examined whether Flag–CKIP-1
and actin capping protein colocalize in osteosarcoma cells (Fig.
5C). DC1.4 cells grown in the absence of tetracycline for 24 h
were fixed, permeabilized, and colabeled with antibodies
against CKIP-1 (polyclonal) and CP (monoclonal). Following
costaining with TRITC- and FITC-labeled secondary antibod-
ies, coverslips were mounted and examined by confocal mi-
croscopy. As previously demonstrated, Flag–CKIP-1 is local-
ized predominantly to the plasma membrane, with staining
evident in membrane ruffles and filopodia. In U2-OS cells,
both CP (Fig. 5C) and CP (data not shown) are localized to
the cell periphery and exhibit punctate staining surrounding
the nuclei. As shown in the overlay (Fig. 5C), Flag–CKIP-1 and
CP colocalize extensively at the cell periphery and in filopo-
dia. Collectively, these data suggest that heterodimeric actin
capping protein is a bona fide interaction partner of CKIP-1.
FIG. 5. Confirmation of CP and CP as bona fide CKIP-1-interacting proteins. CKIP-1 interacts with the heterodimeric actin capping proteins
as shown by coimmunoprecipitations (A and B) and colocalization (C). (A) DC1.4 cells grown in the presence or absence of tetracycline (tet) for
24 h were harvested, and the lysates were subjected to immunoprecipitation (IP) with anti-Flag M2 antibody. Proteins were separated by
SDS-PAGE, transferred to a PVDF membrane, and immunoblotted (IB) with anti-CP or anti-CP antibodies as indicated. (B) U2-0S cells were
transfected with GFP or GFP–CKIP-1 as indicated. Extracts were prepared from the transfected cells, and immunoprecipitations were performed
with anti-GFP antibodies. Immunoprecipitates were separated by SDS-PAGE and transferred to PVDF membranes for immunoblotting with
anti-CP or anti-CP antibodies. The positions of CP, CP, and the heavy and light chains (HC and LC) of IgG are indicated. (C) DC1.4 cells
grown in the absence of tetracycline were fixed, permeabilized, and costained with anti-CKIP-1 antibodies and anti-CP antibodies. The
localization of Flag-CKIP and CP are shown separately and overlaid to show the extent of colocalization. Arrows indicate regions of colocal-
ization. IF, immunofluorescence.
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Elucidation of the domains of CKIP-1 required for interac-
tions with CP. We have previously reported that interactions
between CKIP-1 and protein kinase CK2 are mediated by the
PH domain of CKIP-1 (40). To examine if the PH domain of
CKIP-1 mediates interactions with CP, we generated Flag-
tagged deletions of CKIP-1 for expression in mammalian cells.
These constructs are shown schematically in Fig. 6A. To verify
expression, these constructs were transiently transfected into
U2-OS cells and subjected to immunoblotting with anti-Flag
M2 antibodies (Fig. 6B). All constructs express to the same
degree as or higher than full-length Flag–CKIP-1. To test for
interactions with CP, lysates expressing CKIP-1 deletion con-
structs were subjected to immunoprecipitation with anti-Flag
M2 antibodies, separated by SDS-PAGE, and immunoblotted
with anti-CP antibodies. As shown in Fig. 6C, interaction with
CP is strongest with full-length Flag–CKIP-1. However, bind-
ing is completely abrogated only with deletions lacking amino
acids 133 to 193. Similar results were obtained using GFP-
tagged versions of these deletion constructs (data not shown).
These data suggest that amino acids 133 to 193 of CKIP-1 are
required for interactions with CP. Moreover, this implies that
the domains of CKIP-1 required for binding to protein kinase
CK2 and CP are distinct.
Phosphorylation of tandem affinity-purified CP by protein
kinase CK2. Based on the data demonstrating that protein
kinase CK2 and CP appear to bind distinct regions of CKIP-1,
we tested the hypothesis that CKIP-1 may function as an adap-
tor that targets CK2 to particular cellular compartments to
facilitate the phosphorylation of proteins isolated in CKIP-1
complexes. As shown in Fig. 7A, CP contains a highly con-
FIG. 6. Elucidation of the domains of CKIP-1 required for interaction with CP. CKIP-1 deletions were generated and tested for interaction with
CP by immunoprecipitation. (A) Schematic representation of the Flag-tagged CKIP-1 deletions generated. aa, amino acids. (B) Flag-tagged
CKIP-1 deletions were transfected into U2-OS cells, and the lysates derived from these cells were separated by SDS-PAGE and transferred to
PVDF membranes for immunoblotting (IB) with anti-Flag M2 antibody. (C) CKIP-1 deletions were transfected into U2-OS cells and immuno-
precipitated (IP) with anti-Flag M2 antibodies. Immunoprecipitates were separated by SDS-PAGE and transferred to PVDF membranes for
immunoblotting with anti-CP antibody. Interactions between CKIP-1 and CP require amino acids 133 to 193. HC and LC, IgG heavy and light
chains, respectively.
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served residue within its amino-terminal domain that matches
the consensus sequence [(S/T)XX(D/E/Sp/Yp)] for phosphor-
ylation by protein kinase CK2. This residue (S9) is completely
conserved, with the exception of a conservative change to thre-
onine in Drosophila melanogaster. To examine if CP is a
substrate of protein kinase CK2, we employed TAP tagging to
isolate CKIP-1 and its interaction partners (Fig. 7B, left panel).
Following binding to calmodulin beads, CKIP-1 complexes
were phosphorylated by recombinant protein kinase CK2 in
the presence of Ca2 and [-32P]ATP. The calmodulin beads
were washed, and the bound proteins were eluted and visual-
ized using a PhosphorImager (Fig. 7B, right panel). As shown,
three prominent bands are visible following phosphorylation
by protein kinase CK2. Based on comigration with the bands
stained with Coomassic Blue, we have identified two of these
proteins as TAP-CKIP and CP. At present, we do not know
the identity of the third CK2 target. These data show that CP
is a target of protein kinase CK2 in vitro.
Phosphorylation of CP by protein kinase CK2 in vitro and
in cells. To extend these results, we generated constructs en-
coding HA-tagged CP and Myc-tagged CP for expression of
CP in mammalian cells. Additionally, the putative protein ki-
nase CK2 phosphorylation site serine 9 was mutated to alanine
in order to generate HA-CPS9A. Importantly, we verified
that HA-CP and Myc-CP coimmunoprecipitate with each
other and with Flag–CKIP-1 in U2-OS cell lysates (data not
shown). Next, To examine if protein kinase CK2 phosphory-
lates CP on Ser9 in vitro, U2-OS cells were transfected with
vector alone, HA-CP/Myc-CP, or HA-CPS9A/Myc-CP.
The lysates derived from these cells were analyzed by immu-
noblotting with biotinylated anti-HA antibodies to demon-
strate equal loading of wild-type and mutant CP (Fig. 8A, left
panel). The derived lysates were normalized for protein con-
centration and subjected to immunoprecipitation with anti-HA
antibodies. Bound proteins were phosphorylated with protein
kinase CK2 on the protein A-Sepharose beads in the presence
of [-32P]ATP, separated by SDS-PAGE, and visualized using
a PhosphorImager (Fig. 8A, right panel). As shown, protein
kinase CK2 is able to phosphorylate wild-type HA-CP but not
the mutant HA-CPS9A. These data suggest that in vitro pro-
tein kinase CK2 phosphorylates CP on Ser9.
We next examined if CP found in complexes with Flag–
CKIP-1 is phosphorylated in mammalian cells and if this phos-
phorylation can be modulated using the CK2-specific inhibitor,
TBB. To achieve this objective, DC1.4 cells expressing Flag–
CKIP-1 were grown with carrier (DMSO) or 75 M TBB by
using established procedures (28, 45, 47, 50, 54). Subsequently,
cells were labeled for 6 h with 0.33 mCi of [-32P]orthophos-
phate in the presence of carrier or TBB. Lysates derived from
labeled and nonlabeled control plates were normalized for
protein concentration and subjected to immunoprecipitation
with anti-Flag M2 antibodies. Immunoprecipitates from non-
FIG. 7. Phosphorylation of tandem affinity-purified CP by protein kinase CK2. (A) Alignment of a conserved protein kinase CK2 consensus
site in the amino terminus of CP. The residue serine 9 is conserved in these species, with the exception of a conservation change to a threonine
in D. melanogaster. (B) CKIP-1 complexes were isolated by TAP purification as in the experiment in Fig. 4. Following binding to calmodulin, beads
were left untreated or phosphorylated by recombinant protein kinase CK2 in the presence of [-32P]ATP. The calmodulin beads were washed, and
bound proteins were eluted and separated by SDS-PAGE. The gel was stained with Gel Code Blue to visualize all proteins (left panel) and dried
and exposed in a PhosphorImager to visualize radiolabeled proteins (right panel). The bands identified as TAP–CKIP-1 and CP are indicated.
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labeled plates were transferred to polyvinylidene difluoride
membranes and immunoblotted with anti-CP antibodies (Fig.
8B, left panel). Importantly, treatment with 75 M TBB had
no effect on endogenous CP protein levels. Immunoprecipi-
tates from labeled plates were separated by SDS-PAGE, dried,
and exposed in a PhosphorImager to visualize labeled proteins
(Fig. 8B, right panel). As shown, treatment of DC1.4 cells with
TBB results in a decrease in phosphorylation of CP suggest-
ing that protein kinase CK2 may phosphorylate CP in vivo.
To quantitate CP phosphorylation, the data in Fig. 8B were
analyzed using Image Quant software and expressed as relative
phosphate incorporation (Fig. 8C). Treatment with 75 M
TBB results in a 40% decrease in CP phosphate incorpo-
ration. At present, we do not know whether the failure of TBB
to completely abolish the phosphorylation of CP results from
incomplete inhibition of CK2 or whether other kinases con-
tribute to the phosphorylation of CP in cells. Nevertheless,
taken together, these data suggest that CP is phosphorylated
by protein kinase CK2 on Ser9 in vitro, CP is phosphorylated
in mammalian cells, and protein kinase CK2 can phosphorylate
CP in vivo.
Effects of CKIP-1 on the actin polymerization, depolymer-
ization, and uncapping activity of CP. We used an actin de-
polymerization assay to determine whether interaction with
CKIP-1 altered the capping activity of CP (Fig. 9A). CP inhib-
its the depolymerization of F-actin in a dose-dependent man-
ner on dilution (57). When increasing amounts of CKIP-1 (1,
10, and 50 nM) were added to reaction mixtures with 1 nM CP,
the rate of F-actin depolymerization increased (Fig. 9A). Ad-
dition of CKIP-1 at concentrations above 50 nM had no further
effect (data not shown). Since protein kinase CK2 directly
interacts with CKIP-1, we also asked whether CK2 might exert
FIG. 8. Phosphorylation of CP by protein kinase CK2 in vitro and in cells. (A) Protein kinase CK2 phosphorylates CP on serine 9 in vitro.
HA-CP, HA-CPS9A, and empty vector were transiently transfected into U2-OS cells. (Left panel) Lysates derived from these cells were
immunoblotted (IB) with biotinylated anti-HA antibodies to demonstrate equal loading. (Right panel) The lysates were subjected to immuno-
precipitation (IP) with anti-HA antibodies. Bound proteins were phosphorylated with recombinant protein kinase CK2 on the protein A-Sepharose
beads in the presence of [-32P]ATP, separated by SDS-PAGE, and visualized using a PhosphorImager. The position of HA-CP is indicated. (B
and C) Endogenous CP is phosphorylated in cells, and treatment with a CK2 specific inhibitor results in a decrease in phosphate incorporation.
(B) DC1.4 cells expressing Flag-CKIP-1 were grown in the presence of 75 M TBB or carrier alone for 18 h and labeled with 0.33 mCi of
[-32P]orthophosphate for 6 h. Duplicate plates were treated identically but in the absence of 0.33 mCi of [-32P]orthophosphate. Lysates derived
from these cells were normalized for protein concentration, and subjected to immunoprecipitation with anti-Flag M2 antibodies. (Left panel)
Immunoprecipitates from nonlabeled plates were transferred to PVDF membranes and immunoblotted with anti-CP antibodies. (Right panel)
Immunoprecipitates from labeled plates were separated by SDS-PAGE, dried, and exposed in a PhosphorImager to visualize labeled proteins. The
position of CP is indicated. (C) Data in panel B were analyzed using ImageQuant software and expressed as relative phosphate incorporation.
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an additive effect on the activity of CP. In the presence of 10 to
100 nM protein kinase CK2 and 50 nM CKIP-1, the rate of
actin polymerization was greater than with CKIP-1 alone (Fig.
9A). In a control experiment, 50 nM recombinant protein
kinase CK2 alone with CP had no effect (data not shown).
To further analyze the effects of CKIP-1 and protein kinase
CK2 on actin filament capping, actin polymerization growth
assays were performed (Fig. 9B). Actin polymerization from
barbed ends was initiated by SAS. Addition of 4 nM CP de-
creased the rate of actin polymerization. In agreement with the
depolymerization assays described above, CKIP-1 (80 nM)
partially inhibited capping activity. When we added protein
kinase CK2 (250 nM) and CKIP-1 (80 nM) to the reaction
mixture, the capping activity was further decreased. Reaction
mixtures for both the depolymerization and polymerization
assays contain ATP (0.2 mM), so we asked whether protein
kinase CK2 phosphorylation would affect capping activity. A
kinase-dead mutant of CK2 (CK2-KD) was tested in the
polymerization assay (Fig. 9B) and found to have a similar
effect to that of wild-type CK2. Thus, phosphorylation by pro-
tein kinase CK2 does not contribute to the effect.
Finally, we asked if CKIP-1 and protein kinase CK2 might
promote the uncapping of CP from acting filaments (Fig. 9C).
In a growth assay, CKIP-1 at 80 nM with or without protein
kinase CK2 (250 nM) was added to a polymerization growth
reaction mixture containing CP at a time when most of the
actin filaments were capped (arrow at 250 s in Fig. 9C). They
had no observed effect, while addition of PIP2 as a positive
control induced a large increase in the rate of actin polymer-
ization.
DISCUSSION
Functional investigation of CKIP-1. Despite its discovery
nearly 50 years ago, many details regarding the precise regu-
lation and functions of protein kinase CK2 remain poorly de-
fined. To test the hypothesis that interacting proteins partici-
pate in the regulation of protein kinase CK2, we previously
used the yeast two-hybrid system to identify CK2-interacting
proteins. These studies led to the identification of a novel
CK2-interacting protein designated CKIP-1 (3). To examine
the functions of this novel protein, we generated human os-
teosarcoma cell lines with tetracycline-regulated expression of
Flag–CKIP-1. We observed that cells expressing Flag–CKIP-1
underwent a consistent morphological change that was quan-
titatively documented by morphometric analysis. Furthermore,
we demonstrated that Flag–CKIP-1 expression results in an
increase in F-actin staining in cells and an increase in cellular
protein levels of -actin. To elucidate the mechanisms behind
the observed phenotype, we utilized tandem affinity purifica-
tion and large-scale immunoprecipitations and identified pro-
teins that form complexes with CKIP-1. These studies led to
the identification of the / heterodimeric actin capping pro-
tein interacting with CKIP-1.
Recently, we reported that the PH domain of CKIP-1 is
required for both localization to the plasma membrane and
interactions with protein kinase CK2 (40). Here we demon-
strate that CP binds to a region of CKIP-1 (amino acids 133 to
193) distinct from the PH domain, suggesting that CKIP-1
could mediate interactions between protein kinase CK2 and
CP concurrently. Therefore, we examined if CKIP-1 could
serve as an adaptor to facilitate the phosphorylation of CP.
Our studies indicate that CP is phosphorylated by protein
kinase CK2 in vitro on Ser9. Moreover, we demonstrated that
CP is phosphorylated in osteosarcoma cells and that treat-
ment with the specific protein kinase CK2 inhibitor TBB re-
sults in a reduction in phosphate incorporation in CP. The
use of TBB to specifically inhibit protein kinase CK2 has been
reported extensively in the literature (28, 45, 47, 50, 54). In-
terestingly, treatment with TBB was not sufficient to com-
pletely abolish CP phosphorylation, raising the possibility
that CP is modified by other kinases in addition to protein
kinase CK2. Taken together, these data suggest that one role
of CKIP-1 may be to regulate the ability of CK2 to phosphor-
ylate one of its targets.
We also examined the effect of CKIP-1 and protein kinase
CK2 on the activity of CP in vitro. We observed that CKIP-1
can partially inhibit capping activity as measured in polymer-
FIG. 9. CKIP-1 inhibits the capping activity of CP at the barbed
ends of actin filaments. (A) Actin depolymerization assay. CP (1 nM)
was incubated with various amounts of CKIP and CK2 for 5 min before
being added to 5 M F-actin. Pyrene-actin fluorescence is plotted
against time after dilution. The concentration of CKIP and CK2 incu-
bated with CP is indicated beside each curve. (B) Actin polymerization
assay. Actin polymerization (1 M actin) seeded by the addition of
SAS was monitored by the increase in pyrene fluorescence, with CP,
CKIP, protein kinase CK2, and CK2--kd as indicated. (C) Uncap-
ping assay. CKIP-1 and protein kinase CK2 do not affect the dissoci-
ation of CP from actin filaments. Polymerization of 1.5 M actin at
barbed ends was nucleated by SAS in the presence of CP. After 250 s,
PIP2, CKIP-1, or protein kinase CK2 was added to reaction mixtures
containing 2 nM CP.
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ization and depolymerization assays. This inhibition of CP ac-
tivity was increased by the addition of protein kinase CK2.
Interestingly, this effect was also seen when we used a kinase-
dead mutant of protein kinase CK2. This suggests that phos-
phorylation of CP by protein kinase CK2 does not affect the
activity of CP in vitro. In light of the study by Falck et al. (16)
demonstrating that Ser9 is in the stalk domain of CP—a region
that does not mediate actin binding—this result is not entirely
surprising. However, it is possible that phosphorylation by pro-
tein kinase CK2 affects CP activity or mediates interaction with
CP binding partners in cells. To this end, it is intriguing that
the stalk region of CP containing Ser9 has been implicated in
interactions between CP and the actin monomer binding pro-
tein twinfilin (16). More experimentation is required to exam-
ine if CP phosphorylation by protein kinase CK2 affects the
interactions of CP with twinfilin. Finally, we found that CKIP-1
and protein kinase CK2 did not promote uncapping of CP
from actin filaments.
Role of the actin capping proteins in actin filament assem-
bly. During actin polymerization in nonmuscle cells, actin
monomers are added to the barbed (fast-growing) ends of the
filament. Eventually, the fast-growing barbed ends are capped
by the actin capping protein to stop filament growth in a Ca2-
independent (5, 6, 35, 36) and PIP2-dependent (2, 13, 20, 21)
manner. These actin capping proteins are a family of het-
erodimeric proteins composed of  and  subunits of 35 and
30 kDa, respectively (9, 56). Despite having no sequence
homology, the two subunits have very similar structures, giving
a pseudo-twofold axis of symmetry (58). The proposed func-
tion for actin capping in the dendritic nucleation model (41)
states that most barbed ends are capped so that polymerization
is limited to a small set of free barbed ends that extend quickly.
This model was supported by the observation that depleting
Dictyostelium discoideum of capping protein caused an increase
in the level of F-actin but a decrease in motility (22). Similarly,
in vitro studies with Listeria monocytogenes and purified pro-
teins have shown that when capping protein is removed, the
motility of the bacterium is completely inhibited (32). Like-
wise, depletion of CP by shRNA in B16F1 mouse melanoma
cells resulted in a large increase in filopodia, a marked de-
crease in lamellipodia and increased numbers of actin fila-
ments throughout the cytoplasm (38). Finally, it was recently
demonstrated that expression of CP mutants in Saccharomyces
cerevisiae that fail to interact with actin led to an increase in the
amount of F-actin (27). Collectively, these studies demonstrate
that interference with capping protein leads to stabilization of
actin filaments.
Emerging role for protein kinase CK2 in the actin cytoskel-
eton. There is mounting evidence to suggest that protein kinase
CK2 is involved in regulating cellular morphology and cy-
toskeletal events in a variety of organisms. For example, stud-
ies with S. cerevisiae have demonstrated that interfering with
one CK2 isozyme, but not the other, causes loss of cell polarity
and abnormal chitin deposits in the cell membrane (43). In a
related vein, protein kinase CK2 orb5 mutants of Schizosac-
charomyces pombe demonstrated a role for the kinase in main-
tenance of cell polarity and in polarized cell growth (52). Re-
cently, it was shown that genes encoding -tubulin and protein
kinase CK2 were able to suppress the growth defect associated
with a temperature-sensitive mutant of Arc35p, a member of
the Arp2/3 complex in S. cerevisiae (48). In this study, the
authors demonstrated a biochemical association between CK2
and Arc35p and proposed that this interaction may play a role
in the activation of -tubulin via calmodulin. Additionally, it
was shown that the actin capping protein toxofilin in Toxo-
plasma gondii is regulated by phosphorylation through the ac-
tions of a CK2-like activity and a novel parasitic type 2C phos-
phatase (12). In these studies, CK2 phosphorylation of
toxofilin (or constructs expressing phospho-mimics) caused ac-
tin disassembly in fibroblasts infected with T. gondii. There are
also indications that in mammalian cells CK2 plays a role in
aspects of cytoskeletal regulation. In fact, CK2 has been shown
to play a role in the formation of cell-cell adherens junctions
(30) and actin isolated from muscle preparations has been
shown to inhibit CK2 kinase activity in vitro (24). Finally, a
recent study demonstrated that the VCA domain of WASP is
phosphorylated by protein kinase CK2 in vitro and in cells (10).
Phosphorylation by CK2 was shown to enhance the interaction
of WASP with the Arp2/3 complex and lead to increased actin
polymerization. Collectively, these studies show that protein
kinase CK2 plays a clear, albeit still poorly understood, role in
regulation of the actin cytoskeleton.
Model for the role of CKIP-1–CK2 in cytoskeletal regula-
tion. The data presented in this study demonstrates that
CKIP-1 plays a role in the regulation of the actin cytoskeleton,
interacts with the actin capping protein, and may serve as an
adaptor to facilitate the phosphorylation of CP by protein
kinase CK2. These results strengthen the conclusion that pro-
tein kinase CK2 is involved in regulating the actin cytoskeleton
and cellular morphology. Moreover, the data demonstrating
that CP is phosphorylated by protein kinase CK2 provides an
additional link between CK2 and its role in the regulation of
the actin cytoskeleton. Based on these studies, we propose the
hypothetical model shown in Fig. 10. We propose that when
Flag–CKIP-1 is expressed, interactions between CP and
CKIP-1 interfere with the binding of CP to the barbed ends of
the actin filament. Under these conditions, actin polymeriza-
tion at the plasma membrane would be greatly enhanced. In
support of our model, we have shown that CKIP-1 and protein
kinase CK2 can inhibit the activity of CP in vitro. However,
there are still many questions. For instance, it is not known
how interactions between CKIP-1 and the actin capping pro-
teins lead to the increased level of F-actin and changes in
morphology associated with CKIP-1 expression. However, it is
worth noting that studies of D. discoideum and L. monocyto-
genes demonstrate that interference with capping protein leads
to stabilization of actin filaments and an increase in the level of
F-actin. Recently it was shown that depletion of CP by shRNA
in B16F1 mouse melanoma cells resulted in a large increase in
the numbers of filopodia, a marked decrease in the number of
lamellipodia, and increased numbers of actin filaments
throughout the cytoplasm (38). To this end, we have shown
that Flag–CKIP-1 expression results in increased numbers of
actin filaments and that CKIP-1 and CP colocalize at the
plasma membrane and in filopodia. It is also intriguing that
CKIP-1 binds to phospholipids in vivo and PIP2 in vitro
(40)—a substrate known to inhibit the activity of the actin
capping proteins (2, 13, 20, 21). Similarly, we do not known
what function CP phosphorylation by protein kinase CK2
might serve. More experimentation is needed to answer these
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questions and to determine precisely to what extent the ob-
served effects of CKIP-1 are influenced by CK2 or to what
extent functional effects of CKIP-1 are CK2 independent.
CKIP-1: a new paradigm for regulation of CK2 and the
actin cytoskeleton in cells. An emerging model in the signaling
field is the importance of the clustering and targeting of sig-
naling molecules. One of the best examples of this is the reg-
ulation of cAMP-dependent protein kinase by the AKAP fam-
ily of proteins. Clearly, there are some parallels that can be
drawn between PKA-AKAP interactions and the interactions
between CK2 and CKIP-1. Like PKA, protein kinase CK2 has
multiple substrates localized within a variety of cellular loca-
tions. Based on these similarities, we hypothesized that CKIP-1
is a regulator that functions to target CK2 to particular cellular
localizations in an analogous way to the targeting of PKA by
the AKAP family of proteins. Here we provide evidence that
CKIP-1 may serve to target CK2 to the plasma membrane and
facilitate phosphorylation of the actin capping proteins by pro-
tein kinase CK2. This illustrates an exciting new paradigm
demonstrating how phosphorylation of one specific target by
CK2, a kinase proposed to have hundreds of potential cellular
targets, may be regulated. In a similar respect, there are several
other examples illustrating how the phosphorylation of partic-
ular CK2 subunits is regulated. These include interactions be-
tween protein kinase CK2 and Fas-associated factor FAF-1
(39), TATA binding protein (18), and the nuclear matrix (55).
The present study has strengthened the evidence that protein
kinase CK2 plays a role in the regulation of the actin cytoskel-
eton and cell morphology. Collectively, these results offer new
insights regarding the regulation of one function for a protein
kinase that is involved in a complex series of cellular processes.
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